Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
European Journal of Neurology2022Vol. 30(1), pp. 69–86
Citations Over TimeTop 10% of 2022 papers
Ettore Beghi, Elisabetta Pupillo, Elisa Bianchi, Valentina Bonetto, Silvia Luotti, Laura Pasetto, Caterina Bendotti, Massimo Tortarolo, Francesca Sironi, Laura Camporeale, Alexander Sherman, Sabrina Paganoni, Ada Scognamiglio, Fabiola De Marchi, Paolo Bongioanni, R. Del Carratore, Claudia Caponnetto, Luca Diamanti, Daniele Martinelli, Andrea Calvo, Massimiliano Filosto, Alessandro Padovani, Stefano Cotti Piccinelli, Claudia Ricci, Stefania Dalla Giacoma, Nicoletta De Angelis, Maurizio Inghilleri, Rossella Spataro, Vincenzo La Bella, Giancarlo Logroscino, Christian Lunetta, Claudia Tarlarini, Jessica Mandrioli, Ilaria Martinelli, Cecilia Simonini, Elisabetta Zucchi, Maria Rosaria Monsurrò, Dario Ricciardi, Francesca Trojsi, Nilo Riva, Massimo Filippi, Isabella Laura Simone, Gianni Sorarú, Cristina Spera, Lucía Florio, Sonia Messina, Massimo Russo, Gabriele Siciliano, Amelia Conte, Maria Valeria Saddi, Nicola Carboni, Letizia Mazzini, the RNS60‐ALS Study Group
Abstract
The positive effects of RNS60 on selected measures of respiratory and bulbar function warrant further investigation.
Related Papers
- → Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis(2021)46 cited
- → Amyotrophic Lateral Sclerosis Sera Applied to Cultured Motor Neurons(1974)38 cited
- → Negative results of a phase II study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis(2007)6 cited
- → Genetics of Amyotrophic Lateral Sclerosis(2014)4 cited
- Diagnosis and Treatment of Amyotrophic Lateral Sclerosis(2011)